Angiotensin-converting enzyme inhibitors and progression of renal disease: evidence from clinical studies.
Standard
Angiotensin-converting enzyme inhibitors and progression of renal disease: evidence from clinical studies. / Wenzel, Ulrich.
in: CONTRIB NEPHROL, Jahrgang 135, 2001, S. 200-211.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
Wenzel, U 2001, 'Angiotensin-converting enzyme inhibitors and progression of renal disease: evidence from clinical studies.', CONTRIB NEPHROL, Jg. 135, S. 200-211. <http://www.ncbi.nlm.nih.gov/pubmed/11705285?dopt=Citation>
APA
Wenzel, U. (2001). Angiotensin-converting enzyme inhibitors and progression of renal disease: evidence from clinical studies. CONTRIB NEPHROL, 135, 200-211. http://www.ncbi.nlm.nih.gov/pubmed/11705285?dopt=Citation
Vancouver
Wenzel U. Angiotensin-converting enzyme inhibitors and progression of renal disease: evidence from clinical studies. CONTRIB NEPHROL. 2001;135:200-211.
Bibtex
@article{dcd3073c72f54cc28188039c2937e8a5,
title = "Angiotensin-converting enzyme inhibitors and progression of renal disease: evidence from clinical studies.",
author = "Ulrich Wenzel",
year = "2001",
language = "Deutsch",
volume = "135",
pages = "200--211",
}
RIS
TY - JOUR
T1 - Angiotensin-converting enzyme inhibitors and progression of renal disease: evidence from clinical studies.
AU - Wenzel, Ulrich
PY - 2001
Y1 - 2001
M3 - SCORING: Zeitschriftenaufsatz
VL - 135
SP - 200
EP - 211
ER -
